Vaxart, Inc.
VXRT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000072444
No open-market purchases or sales by Vaxart, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $39.0K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Vaxart, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 109
- −21 vs. Q4 2022
- Shares held
- 34.1M
- −10.2M (−23.1%) vs. Q4 2022
- Total value
- $25.8M
- −$16.8M (−39.4%) vs. Q4 2022
- New holders
- 8
- 30 more added
- Sold out
- 29
- 36 more reduced
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VXRT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $39.0K |
| Q1 2026 | 5 | $34.2K |
| Q4 2025 | 5 | $22.2K |
| Q3 2025 | 17 | $839.9K |
| Q2 2025 | 98 | $10.3M |
| Q1 2025 | 92 | $11.1M |
| Q4 2024 | 93 | $23.7M |
| Q3 2024 | 100 | $31.9M |
| Q2 2024 | 100 | $27.0M |
| Q1 2024 | 104 | $52.3M |
| Q4 2023 | 87 | $9.38M |
| Q3 2023 | 96 | $13.9M |
| Q2 2023 | 111 | $21.1M |
| Q1 2023 | 109 | $25.8M |
| Q4 2022 | 132 | $42.6M |
| Q3 2022 | 143 | $110.7M |
| Q2 2022 | 146 | $155.6M |
| Q1 2022 | 148 | $226.3M |
| Q4 2021 | 147 | $267.9M |
| Q3 2021 | 141 | $297.5M |
| Q2 2021 | 143 | $260.6M |
| Q1 2021 | 159 | $195.1M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Vaxart, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Charles Schwab Investment Management Inc | 993,223 | $751.6K | 0.00% | +18,038+1.8% | Added |
| Two Sigma Advisers, LP | 1,099,500 | $832.0K | 0.00% | −957,500−46.5% | Reduced |
| Northern Trust Corp | 1,123,363 | $850.0K | 0.00% | +43,042+4.0% | Added |
| Two Sigma Investments, LP | 1,194,023 | $903.5K | 0.00% | −1,440,693−54.7% | Reduced |
| Nuveen Asset Management, LLC | 2,219,532 | $1.68M | 0.00% | +1,210,794+120.0% | Added |
| State Street Corp | 2,653,619 | $2.01M | 0.00% | +255,355+10.6% | Added |
| Geode Capital Management, LLC | 2,662,473 | $2.01M | 0.00% | +82,949+3.2% | Added |
| Vanguard Group Inc | 7,063,886 | $5.35M | 0.00% | +44,379+0.6% | Added |
| BlackRock Inc. | 8,818,647 | $6.67M | 0.00% | −39,578−0.4% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −882,456−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −742,446−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −544,239−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −311,764−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −231,204−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −128,354−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −125,502−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −103,363−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −66,887−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −46,137−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −38,563−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −22,169−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −21,786−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −21,235−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −15,396−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −14,121−100.0% | Sold out |
| Bleakley Financial Group, LLC | 0 | $0 | 0.00% | −13,788−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −10,931−100.0% | Sold out |
| Activest Wealth Management | 0 | $0 | 0.00% | −10,440−100.0% | Sold out |
| Financial Engines Advisors L.L.C. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| RPg Family Wealth Advisory, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Kestra Private Wealth Services, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −8,060−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −6,157−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −952−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Pathstone Family Office, LLC | 0 | $0 | 0.00% | −860−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −712−100.0% | Sold out |
| Gofen & Glossberg LLC | – | – | – | – | Not filed |
| CoreCap Advisors, LLC | – | – | – | – | Not filed |